07:00 , Oct 17, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Retinoic acid receptor responder (tazarotene induced) 1 (RARRES1; TIG1); AXL receptor tyrosine kinase (AXL; UFO) In vitro and mouse...